Filtered By:
Management: Electronic Medical Records (EMR)
This page shows you your search results in order of date. This is page number 8.
Order by Relevance | Date
Total 270 results found since Jan 2013.
Anaphylaxis in Omani Patients: A Study from a Tertiary Care Center
CONCLUSIONS: Due to its life-threatening nature, knowledge of the epidemiology and clinical features of anaphylaxis in different populations is necessary to deliver rapid treatment. This study found that the clinical features of anaphylactic patients in Oman were similar to those reported elsewhere. Further research is needed to determine the true incidence of anaphylaxis in Oman to minimize associated morbidity and mortality.PMID:35136659 | PMC:PMC8804154 | DOI:10.5001/omj.2021.113
Source: Oman Medical Journal - February 9, 2022 Category: Middle East Health Authors: Salem Al Tamemi Yusra Al Lamki Shafiq Ur-Rehman Naseem Nabila Al Siyabi Bushra Al Siyabi Ibrahim Al-Zakwani Source Type: research
Severe asthma biologic treatment in the era of COVID-19 - case series
Conclusions: Only a minority of this population tested positive for COVID-19 and none of them developed serious disease, supporting the evidence that both severe type-2 asthma and its targeted treatment do not convey increased risk for disease. However, additional studies regarding long-term complications should also be performed.
Source: European Respiratory Journal - November 25, 2021 Category: Respiratory Medicine Authors: Costa, P. M. N., Loureiro, C. C. Tags: Allergy and immunology Source Type: research
Pharmacies Often Not Notified of Discontinued Rx
Interventions, including phoning pharmacies and enabling CancelRX in electronic medical records, may reduce risk for medication safety events
Source: The Doctors Lounge - Psychiatry - September 29, 2021 Category: Psychiatry Tags: Cardiology, Dermatology, Endocrinology, Family Medicine, Geriatrics, Gastroenterology, Gynecology, Infections, AIDS, Internal Medicine, Allergy, Nephrology, Neurology, Nursing, Oncology, Ophthalmology, Orthopedics, ENT, Pediatrics, Pharmacy, Psychiatry, P Source Type: news
Use of electronic medical records to describe the prevalence of allergic diseases in Canada
Leveraging the data management resources of the Canadian Primary Care Sentinel Surveillance Network (CPCSSN) is a viable approach for describing the prevalence of allergic disease documented in primary care se...
Source: Allergy, Asthma and Clinical Immunology - August 18, 2021 Category: Allergy & Immunology Authors: Alexander G. Singer, Leanne Kosowan, Nerissa Nankissoor, Ryan Phung, Jennifer L. P. Protudjer and Elissa M. Abrams Tags: Short Report Source Type: research
Tylenol or acetaminophen: a recurrent fixed drug eruption perpetuated through the use of inconsistent drug terminology
BMJ Case Rep. 2021 Aug 3;14(8):e241908. doi: 10.1136/bcr-2021-241908.ABSTRACTAn 87-year-old man with a history of osteoarthritis presented with worsening knee pain. He was prescribed acetaminophen with codeine. A few days later, he developed a rash on his right buttock and proximal thigh, similar to a rash he experienced in the past when he took over-the-counter (OTC) acetamenophen and an unknown lozenge to treat a presumed viral illness. A fixed drug eruption (FDE) was diagnosed and the patient was asked to avoid Tylenol and other OTC lozenges. Tylenol was entered as an allergy in the electronic medical records. However, ...
Source: Pain Physician - August 4, 2021 Category: Anesthesiology Authors: Daniel Federman Jadry A Gruen Naseema Merchant Source Type: research
Immunoallergic disorders in the elderly
Eur Ann Allergy Clin Immunol. 2021 May 5. doi: 10.23822/EurAnnACI.1764-1489.211. Online ahead of print.ABSTRACTAlthough allergic diseases have become increasingly prevalent in the elderly, there are few data on this population. Through a retrospective analysis of the electronic medical records of patients aged 65 years and above followed in our Immunoallergology Unit, we aimed to characterize the immunoallergic diseases of the elderly. The most common disorders were respiratory diseases (n = 185; 50%), mucocutaneous diseases (n = 113; 31%), drug allergy (n = 31; 8%), food allergy (n = 9; 2%), and anaphylaxis (n = 9; 2%). U...
Source: European Annals of Allergy and Clinical Immunology - May 5, 2021 Category: Allergy & Immunology Authors: G Martins-Dos-Santos M Ara újo S Prates P Leiria-Pinto Source Type: research
